Drug Repositioning: Current Advances and Future Perspectives

• Auteur principal: Yuhei Nishimura (auth)
• Autres auteurs: Hideaki Hara (auth)
• Format: Électronique Chapitre de livre
• Langue: anglais
• Publié: Frontiers Media SA 2019
• Collection: Frontiers Research Topics
• Sujets: Pharmacology; database; Integrative strategies; molecular docking; polypharmacology; multi-omics; computational analysis; Drug Repositioning; data sharing; Patenting
• Accès en ligne: DOAB: download the publication; DOAB: description of the publication

Drug repositioning is the process of identifying new indications for existing drugs. At present, the conventional de novo drug discovery process requires an average of about 14 years and US$2.5 billion to approve and launch a drug. Drug repositioning can reduce the time and cost of this process beca...